Companies category powered by

Medochemie extends humanitarian aid to Gaza civilians

Medochemie is actively supporting the civilian population in the Gaza Strip, dispatching a shipment of 10 tons of injectable hospital antibiotics and paediatric medicines to local medical facilities.

Medochemie Ltd is a multinational generics pharmaceutical and consumer healthcare company headquartered in Limassol. Medochemie develops, licenses, manufactures, markets, and distributes branded generic products as well as their own patented brands.

According to a press release from the company, the shipment was sent in collaboration with the NGO Cyprus Stop Trafficking, the assistance from Volunteer Doctors Cyprus, and the support of Polly Ioannou, Ambassador of the Republic of Cyprus in Cairo.

The 10 tons of medicines have been shipped from the port in Limassol and have arrived in Egypt aiming to reach final destination in the next few days, the press release noted.

“The value of human life is sacred, and as the largest pharmaceutical company in Cyprus, Medochemie could not remain indifferent to the profound medical needs of our fellow human beings,” the company’s press release said, adding, “The values of solidarity and contribution are deeply ingrained in Medochemie culture. With an unwavering commitment to the principles and ethos that have long defined our company's management and staff.”

Read More

FIRST Corporate Padel Tournament in Cyprus
Thousands participate in the 23rd McDonald’s Ayia Napa Youth Soccer Festival
Cyprus Airways takes flight with a greener, smarter travel experience on board new Airbus A220
New Remedica CEO Andrew Bird addresses Employee Town Hall
Intellectual Property: The importance of the Supreme Court's decision and the need for the establishment of a Copyright Authority
G.A.P. Vassilopoulos' documented proposal for combatting the water shortage
Universal Life selects Sapiens to modernise its core systems
17th IN Business Awards: Just over a week left to cast your vote
17th IN Business Awards: Have you voted yet?
GOLD New Issue: Casting an Eye on AI